相关实验视频

Updated: Jul 27, 2026

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction

Published on: January 3, 2020

新辅助疗法协会关于胰腺腺腺癌的病理和临床结果

Nicholas Galouzis¹, Maria Fotinos¹, Evelyn V Alexander¹

¹Department of Surgery, University of Arizona, Tucson, Arizona.

The Journal of surgical research

|January 8, 2026

概括

完成六个月的化疗改善了胰腺癌患者的生存率. 与周围手术或辅助化疗相比,全新辅助化疗 (TNC) 可能会增加完成率.

科学领域:

在瘤学瘤学.
手术瘤学手术瘤学
胃肠病学胃肠病学

背景情况:

胰腺管腺癌 (PDAC) 治疗正在发展.
总的新辅助化疗 (TNC) 使用正在增加PDAC.
了解化疗时间对生存的影响至关重要.

研究的目的:

评估化疗时间 (TNC,术后,辅助) 与PDAC的整体存活率之间的关联.
为了比较不同治疗时间的化疗完成率.
评估完成6个月化疗对生存的影响.

主要方法:

对115名接受切除和化疗的PDAC患者 (2020-2023) 的回顾性分析.
在TNC,外科手术期间 (PERIOP) 和辅助剂 (ADJ) 组之间比较整体生存率和化疗完成率.
所有患者的预期六个月的化疗疗程.

主要成果:

在TNC,PERIOP和ADJ组中,平均存活时间相似 (43,40,38个月;P=0.70).
化学疗法完成率在TNC (100%) 与PERIOP (40.6%) 和ADJ (36.1%) 组相比显著更高 (P<0.01).
完成6个月化疗的患者与没有完成 (6个月;P<0.01) 的患者相比,平均整体存活期 (43个月) 改善了.

结论:

六个月的化疗完成,无论时间如何,都与PDAC中更好的生存结果有关.
由于术后完成率较低,TNC可能会提高化疗完成率.
优化化疗输送是提高PDAC患者生存率的关键.

关键词:

总体生存率总体生存率胰腺腺癌是什么?胰腺腺腺癌是什么?总的新辅助化学疗法总量

更多相关视频

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors

Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors

Published on: February 9, 2024

相关概念视频

Acute Pancreatitis I: Introduction

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:

Acute Pancreatitis II: Clinical Manifestations and Management

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Acute Pancreatitis I: Introduction

Acute Pancreatitis I: Introduction

Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...